3/24
05:01 pm
pepg
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
3/19
10:00 am
pepg
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
3/17
05:28 pm
pepg
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
3/12
06:30 pm
pepg
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
High
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
3/5
08:00 pm
pepg
PepGen Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Medium
Report
PepGen Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
3/5
02:53 pm
pepg
PepGen: Stock Slides On FDA Study Hold - I'm Firmly On The Sidelines [Seeking Alpha]
Low
Report
PepGen: Stock Slides On FDA Study Hold - I'm Firmly On The Sidelines [Seeking Alpha]
3/5
02:31 pm
pepg
PepGen muscular dystrophy drug gets ‘surprise' hold from FDA [Yahoo! Finance]
Low
Report
PepGen muscular dystrophy drug gets ‘surprise' hold from FDA [Yahoo! Finance]
3/5
04:35 am
pepg
PepGen GAAP EPS of -$0.27 beats by $0.12 [Seeking Alpha]
Low
Report
PepGen GAAP EPS of -$0.27 beats by $0.12 [Seeking Alpha]
3/4
05:13 pm
pepg
US FDA puts partial clinical hold on PepGen's muscle disease drug trial [Yahoo! Finance]
Low
Report
US FDA puts partial clinical hold on PepGen's muscle disease drug trial [Yahoo! Finance]
3/4
04:28 pm
pepg
PepGen Announces Regulatory Updates on FREEDOM2 [Yahoo! Finance]
High
Report
PepGen Announces Regulatory Updates on FREEDOM2 [Yahoo! Finance]
3/4
04:28 pm
pepg
PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
Low
Report
PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
3/4
04:05 pm
pepg
PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights
High
Report
PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights
3/4
04:03 pm
pepg
PepGen Announces Regulatory Updates on FREEDOM2
High
Report
PepGen Announces Regulatory Updates on FREEDOM2
3/3
07:12 am
pepg
PepGen to Participate in the Leerink Global Healthcare Conference [Yahoo! Finance]
Medium
Report
PepGen to Participate in the Leerink Global Healthcare Conference [Yahoo! Finance]
3/3
07:00 am
pepg
PepGen to Participate in the Leerink Global Healthcare Conference
Medium
Report
PepGen to Participate in the Leerink Global Healthcare Conference
2/25
12:58 pm
pepg
PepGen (PEPG) is now covered by Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $15.00 price target on the stock.
Low
Report
PepGen (PEPG) is now covered by Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $15.00 price target on the stock.
2/18
08:06 am
pepg
PepGen (NASDAQ:PEPG) had its "buy" rating reaffirmed by analysts at Guggenheim.
Medium
Report
PepGen (NASDAQ:PEPG) had its "buy" rating reaffirmed by analysts at Guggenheim.